ESMO 2022 - NICHE-2 and Codebreak 200
Sep 15, 2022•12 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
ESMO 2022 is wrapped and two studies in particular have caught our eyes:
NICHE-2: neoadjuvant Nivo/Ipi in MMR-d colon cancer
CODEBREAK: sotorasib vs. docetaxel
For the best experience, listen in Metacast app for iOS or Android